SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bio-Path Holdings, Inc. Begins Enrollment in Fourth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemias